Fundraising FoxPalvella Therapeutics
Wayne, US · Founded 2015 · 3 known investors
Find your way into Palvella Therapeutics
Sign up to see every warm intro you have to Palvella Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Palvella Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Clinical-stage company developing topical therapies for rare skin diseases via its QTORIN platform.
Founders & leadership
Palvella Therapeutics was founded in 2015 by Wesley H. Kaupinen.
WH
Wesley H. KaupinenFounder
Board
TD
Todd DavisBoard director
TH
Timothy HenkelBoard director
MC
Michael ChristopherBoard director
EH
Elaine HeronBoard director
DT
David TierneyBoard director
GJ
George JenkinsBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$63.9M disclosed across 4 rounds · 2018–2022
▶$9.7MraisedDec 2022 · 33 investors · BiotechnologyRule 506(b)
▶$9.7MraisedDec 2022 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aditya AsokanDirector
- Wesley H. KaupinenExecutive Officer, Director
- Jeffrey MartiniExecutive Officer
- Tadd S WesselDirector
- Kathleen McGowanExecutive Officer
- George JenkinsDirector
- Todd DavisDirector
- Scott MorensteinDirector
- Kathleen GoinExecutive Officer
- Offering amount
- $37.7M
- Amount sold
- $9.7M
- Sales commissions
- $319.6K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$45MraisedJun 2020 · 48 investors · BiotechnologyRule 506(b)
▶$45MraisedJun 2020 · 48 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kathleen A. McGowanExecutive Officer
- Kathleen GoinExecutive Officer
- Wesley H. KaupinenExecutive Officer, Director
- John DouxDirector
- Scott MorensteinDirector
- George JenkinsDirector
- Cory FreedlandDirector
- Todd DavisDirector
- Braham Shroot, Ph.D.Executive Officer
- Elaine HeronDirector
- Offering amount
- $45M
- Amount sold
- $45M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$4.8MraisedAug 2019 · 47 investors · BiotechnologyRule 506(b)
▶$4.8MraisedAug 2019 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wesley H. KaupinenExecutive Officer, Director
- Todd DavisDirector
- Michael ChristopherDirector
- Timothy HenkelDirector
- John DouxDirector
- Elaine HeronDirector
- George JenkinsDirector
- Offering amount
- $5M
- Amount sold
- $4.8M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$4.4MraisedJun 2018 · 40 investors · BiotechnologyRule 506(b)
▶$4.4MraisedJun 2018 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wesley H. KaupinenExecutive Officer, Director
- Timothy HenkelDirector
- Michael ChristopherDirector
- Elaine HeronDirector
- David TierneyDirector
- Todd DavisDirector
- George JenkinsDirector
- Offering amount
- $5M
- Amount sold
- $4.4M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Palvella Therapeutics do?
- Clinical-stage company developing topical therapies for rare skin diseases via its QTORIN platform.
- Who founded Palvella Therapeutics?
- Palvella Therapeutics was founded by Wesley H. Kaupinen in 2015.
- Who are Palvella Therapeutics's investors?
- Palvella Therapeutics's investors include Agent Capital, BioAdvance, Frazier Life Sciences.
- How much funding has Palvella Therapeutics raised?
- Palvella Therapeutics has disclosed $63.9M raised across 4 rounds.
- Where is Palvella Therapeutics headquartered?
- Palvella Therapeutics is headquartered in Wayne, US.